Dynavox Group AB (publ) (STO: DYVOX)
Sweden
· Delayed Price · Currency is SEK 56.50
-0.30 (-0.53%)
At close: Dec 20, 2024
Dynavox Group AB Revenue
Dynavox Group AB had revenue of 483.00M SEK in the quarter ending September 30, 2024, with 13.92% growth. This brings the company's revenue in the last twelve months to 1.86B, up 23.76% year-over-year. In the year 2023, Dynavox Group AB had annual revenue of 1.61B with 32.63% growth.
Revenue (ttm)
1.86B
Revenue Growth
+23.76%
P/S Ratio
3.19
Revenue / Employee
2.32M
Employees
701
Market Cap
5.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 1.61B | 396.90M | 32.63% |
| Dec 31, 2022 | 1.22B | 344.80M | 39.56% |
| Dec 31, 2021 | 871.60M | -23.60M | -2.64% |
| Dec 31, 2020 | 895.20M | -13.60M | -1.50% |
| Dec 31, 2019 | 908.80M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca PLC | 519.35B |
| Swedish Orphan Biovitrum AB (publ) | 25.44B |
| Sectra AB (publ) | 3.14B |
| Getinge AB (publ) | 33.59B |
| Camurus AB (publ) | 1.69B |
| Medicover AB (publ) | 22.60B |
| Vitrolife AB (publ) | 3.56B |
| Bonesupport Holding AB (publ) | 814.46M |